On June 3, 2025, ABVC Biopharma, Inc. held its annual shareholder meeting where shareholders re-elected 11 directors, ratified the appointment of an accounting firm, approved a land purchase transaction, and increased the equity incentive plan. The meeting had a quorum with 5,917,309 shares represented, indicating strong shareholder participation.